RE:RE:Weighing in on SPHi F,
I am not making a final judgement about PoNs and whether it is effective or not.
All my comments are meant to relate to the clinical trial and interpretation of it.
To me this is the point.
There may be substantial supporting data that demonstrate efficacy and benefit of PoNs, but that is separate and independent from the rigorous and strict interpretation of the study.
I referred to this in the thread in the part on conflating results.
Understanding how scientists interpret results is essential to predicting the FDA decision.
The result becomes less surprising then, notwithstanding all the other data many here have made
Maybe PONS is a game changer, maybe it will help many people
This is not what ai was addressing, here, and I hope this makes sense
Anyway, I really don’t post much, because again, I do not find it to be a great use of my time, but I did with the Original post when I was reading the comments and interpretation of the study which I felt to be incorrect.
I really do think there is important lesson to be learned from this discussion.
At the end of the day, I really am sorry for folks that lost money, and for patients that are afflicted with these diseases.
I only wish people well(including Prokiev) and my time on this board was in the spirit of objective analysis of the data, and through discussion, an attempt to clarify the meaning, and improve our abilities of investors(including me as articulating this makes you organize your thoughts)
This thinking led me away from an investment and keeps me on the sidelines
As a result, I really am leaving the discussion as I have little to offer.
I wish everyone well, and wish you all well with your investing.
Good luck everyone, and I wish you the best.